Should You Invest in This Artificial Intelligence (AI) IPO Stock That Has a Partnership with Amazon?

X-Energy’s IPO price was $23 per share and the stock is still up 30% from that level, but the company remains unprofitable and has only $109 million of revenue and grant income versus a $390 million comprehensive loss in 2025. It is targeting its first reactors by 2030 and a 5 GW Amazon partnership by 2039, but commercialization is still years away and execution risk remains high. The article is cautiously negative on X-Energy relative to better-established clean-energy and AI infrastructure plays.

Analysis

The market is effectively valuing X-Energy as a de-risked infrastructure asset before it has earned that status. The hidden issue is not technology feasibility, but financing convexity: every delay in first deployment forces more equity dilution or expensive project-level capital, while hyperscaler demand remains optional until power purchase agreements convert into operating plants. That creates a classic pre-revenue mismatch where headlines about capacity partnerships can support the stock for quarters, but fundamentals are likely to lag by years.

The more important second-order winner is Amazon, not the reactor developer. If modular nuclear becomes part of the data-center power stack, AMZN gains an advantage in power procurement optionality, site selection, and long-duration baseload pricing versus cloud peers that rely more heavily on grid interconnection or short-cycle renewables. Dow and other industrial off-takers matter too: they are effectively helping validate the technology, which can improve project finance terms across the sector, but also means the competitive bottleneck may shift to fuel supply, licensing, and construction execution rather than demand.

The contrarian setup is that the public market may be too optimistic on timing, but not necessarily on end-state value. The next 12–24 months are likely to be dominated by engineering milestones, NRC/regulatory checkpoints, and capital raises, not meaningful revenue inflection; however, a single credible site commissioning timeline could rerate the entire SMR basket sharply. The biggest downside tail risk is a “science-project” narrative reset if first-of-a-kind units slip beyond 2030, which would pressure all pre-commercial nuclear names and redirect capital toward nearer-term grid and gas solutions.

Key Decisions for Investors

• Avoid chasing XE post-IPO strength; wait for either a pullback toward IPO price support or a definitive reactor licensing milestone. Risk/reward is poor while commercialization remains 4-5 years out and dilution risk is open-ended.
• Long AMZN vs short a basket of pre-profit nuclear developers (XE/OKLO/SMR) over 6-12 months. The thesis is that Amazon captures the strategic option value of nuclear optionality with far lower execution risk, while the developers remain funding-dependent.
• Pair trade: long DOW, short XE on any nuclear hype rallies. Dow gets validation from industrial decarbonization without needing first-of-kind reactor execution, while XE bears the burden of construction, fuel qualification, and regulatory slippage.
• For speculative exposure, use call spreads on OKLO or SMR rather than outright long XE shares. These names are more levered to sentiment rerating, but cap downside if the market re-prices commercialization timelines.
• Set a 12-month catalyst watch: if XE announces a firm EPC contract with fixed-cost terms or a fully financed first deployment, reassess immediately. Until then, treat all partner announcements as financing support, not earnings visibility.